-
Signature
-
/s/ Patrick J. Christmas as attorney-in-fact
-
Issuer symbol
-
RGNX
-
Transactions as of
-
09 Oct 2025
-
Net transactions value
-
-$262,635
-
Form type
-
4
-
Filing time
-
10 Oct 2025, 18:38:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Simpson Curran |
Chief Executive Officer, Director |
C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE |
/s/ Patrick J. Christmas as attorney-in-fact |
10 Oct 2025 |
0001346164 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RGNX |
Common Stock |
Sale |
$262,635 |
-20,811 |
-8.8% |
$12.62 |
216,162 |
09 Oct 2025 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: